Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sigilon Therapeutics, Inc. | 8,888 | reported | 26 May 2022 | tx 2+26,665 |
| LivaNova PLC | 6,232 | reported | 18 Nov 2025 | tx 14+19,684−9,410 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Nov 2025 | SALE | LivaNova PLC | 250 | 53.94 USD | |
| 15 Jun 2025 | TAX_WITHHOLDING | LivaNova PLC | 410 | 45.76 USD | |
| 15 Jun 2025 | EXERCISE | LivaNova PLC | 3,416 | 0.00 USD | |
| 15 Jun 2025 | EXERCISE | LivaNova PLC | 3,416 | 0.00 USD | deriv |
| 15 Jun 2025 | GRANT_AWARD | LivaNova PLC | 4,042 | 0.00 USD | deriv |
| 15 Jun 2024 | TAX_WITHHOLDING | LivaNova PLC | 584 | 52.68 USD | |
| 15 Jun 2024 | EXERCISE | LivaNova PLC | 2,680 | 0.00 USD | |
| 15 Jun 2024 | GRANT_AWARD | LivaNova PLC | 3,416 | 0.00 USD | deriv |
| 15 Jun 2024 | EXERCISE | LivaNova PLC | 2,680 | 0.00 USD | deriv |
| 15 Sept 2023 | TAX_WITHHOLDING | LivaNova PLC | 345 | 57.80 USD | |
| 15 Sept 2023 | EXERCISE | LivaNova PLC | 1,725 | 0.00 USD | |
| 15 Sept 2023 | EXERCISE | LivaNova PLC | 1,725 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | LivaNova PLC | 2,680 | 0.00 USD | deriv |
| 15 Sept 2022 | GRANT_AWARD | LivaNova PLC | 1,725 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Sigilon Therapeutics, Inc. | 8,888 | 0.00 USD | deriv |
| 14 Jun 2021 | GRANT_AWARD | Sigilon Therapeutics, Inc. | 17,777 | 0.00 USD | deriv |